Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

DAR 0100A

Known as: DAR-0100A, DAR0100A 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Abstract Background Accumulating evidence indicates that cognitive remediation(CR) is effective for improving various cognitive… Expand
Is this relevant?
2018
2018
Abstract Background Abnormalities in cognition and social cognition represent a core feature of the schizophrenia spectrum… Expand
Is this relevant?
2016
2016
Background: Evidence from preclinical and human studies indicates the presence of reduced dopamine-1 receptor (D1R) signaling in… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 3
Is this relevant?
Highly Cited
2015
Highly Cited
2015
Pharmacological enhancement of prefrontal D1 dopamine receptor function remains a promising therapeutic approach to ameliorate… Expand
  • table 1
  • table 2
  • figure 1
Is this relevant?
Review
2014
Review
2014
Cite this article as: Daniel R Rosell, Lauren C Zaluda, Margaret M McClure, M Mercedes Perez-Rodriguez, K Sloan Strike, Deanna M… Expand
  • table 1
  • table 2
Is this relevant?
2011
2011
DAR-0100A, the active enantiomer of dihydrexidine, is a potent dopamine D1 agonist under investigation for treatment of cognitive… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
Is this relevant?